170 related articles for article (PubMed ID: 23032887)
1. Risk of second cancers after photon and proton radiotherapy: a review of the data.
Yock TI; Caruso PA
Health Phys; 2012 Nov; 103(5):577-85. PubMed ID: 23032887
[TBL] [Abstract][Full Text] [Related]
2. Incidence of second malignancies among patients treated with proton versus photon radiation.
Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
[TBL] [Abstract][Full Text] [Related]
3. Subsequent malignancies after photon versus proton radiation therapy.
Bekelman JE; Schultheiss T; Berrington De Gonzalez A
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):10-2. PubMed ID: 23810521
[No Abstract] [Full Text] [Related]
4. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
Tubiana M
Radiother Oncol; 2009 Apr; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
[TBL] [Abstract][Full Text] [Related]
5. Modelling recurrence and second cancer risks induced by proton therapy.
Manem VSK; Dhawan A
Math Med Biol; 2018 Sep; 35(3):347-361. PubMed ID: 29106564
[TBL] [Abstract][Full Text] [Related]
6. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
Simone CB; Kramer K; O'Meara WP; Bekelman JE; Belard A; McDonough J; O'Connell J
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):242-9. PubMed ID: 21236595
[TBL] [Abstract][Full Text] [Related]
7. Pediatric CSI: are protons the only ethical approach?
Johnstone PA; McMullen KP; Buchsbaum JC; Douglas JG; Helft P
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):228-30. PubMed ID: 23958143
[No Abstract] [Full Text] [Related]
8. [The issue of low doses in radiation therapy and impact on radiation-induced secondary malignancies].
Chargari C; Cosset JM
Bull Cancer; 2013 Dec; 100(12):1333-42. PubMed ID: 24257106
[TBL] [Abstract][Full Text] [Related]
9. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation.
Schneider U; Lomax A; Lombriser N
Radiat Res; 2000 Oct; 154(4):382-8. PubMed ID: 11023601
[TBL] [Abstract][Full Text] [Related]
10. Proton therapy in the management of lymphoma.
Ho CK; Flampouri S; Hoppe BS
Cancer J; 2014; 20(6):387-92. PubMed ID: 25415683
[TBL] [Abstract][Full Text] [Related]
11. Reducing second breast cancers: a potential role for prophylactic mammary irradiation.
Brenner DJ; Shuryak I; Russo S; Sachs RK
J Clin Oncol; 2007 Nov; 25(31):4868-72. PubMed ID: 17971581
[No Abstract] [Full Text] [Related]
12. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
[TBL] [Abstract][Full Text] [Related]
13. Comparative treatment planning using secondary cancer mortality calculations.
Schneider U; Lomax A; Lombriser N
Phys Med; 2001; 17 Suppl 1():97-9. PubMed ID: 11770547
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
15. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
18. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
19. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
20. Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status.
Takam R; Bezak E; Marcu LG; Yeoh E
Radiat Res; 2011 Oct; 176(4):508-20. PubMed ID: 21756083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]